Pre-treatment follow up
OtherNo active intervention; medical support provided if needed
NCT Number: NCT02769013
Assessing the effect of neglected tropical diseases on Plasmodium falciparum transmission in an area of co endemicity.
Looking for future studies?
Notify Me6 year–30 year
All sexes
Observational
Ayôla Akim ADEGNIKA, Lambaréné, Albert Schweitzer Hospital, Gabon
The project is divided in three different work packages that cover the life cycle of P. falciparum :
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No active intervention; medical support provided if needed
Praziquantel-treatment for S. haematobium positive volunteers
Other names: Praziquantel-treatment
No active intervention; medical support provided if needed.
No active intervention; medical support provided if needed.
Time frame: 15 months
Presence of Plasmodium falciparum gametocytes and/or asexual blood stages will be assessed by a quantitative real-time PCR assay in the blood obtained from participants. Unit of measurements for both parameters is numbers/µl.
Time frame: 15 months
Number of participants with serum antibodies against P. falciparum gametocyte and/or asexual blood stage antigens will be assessed.
Time frame: 15 months
100 mosquitoes will be released to Schistosoma infected and non-infected participants simultaneously lying in different tents in a two-way olfactometer.
Time frame: 3 months
Mosquitoes will be collected by Human Landing catches and species of mosquitoes and presence of Plasmodium falciparum will be determined by morphology and PCR.
University Hospital Tuebingen
Other
Acronym: TRANSMAL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07389057
Infections, Malaria
Accra, Eastern Region, Ghana
View Trial DetailsNCT07387341
Infections, Malaria
Kisumu, Kenya
View Trial DetailsNCT06881732
Infections, Malaria
Melbourne, Victoria, Australia
View Trial Details